MCHP
37
3
DAL
64
3
COF
52
5
NUE
41
2
PLD
40
2
EXPE
88
2
PNR
60
3
V
76
8
ROST
62
2
DGX
29
2
ROP
48
3
HP
38
4
APH
58
5
YUM
43
3
NAVI
40
7
APA
35
3
KEY
27
3
GIS
37
2
TEL
60
2
O
30
10
MCHP
37
3
DAL
64
3
COF
52
5
NUE
41
2
PLD
40
2
EXPE
88
2
PNR
60
3
V
76
8
ROST
62
2
DGX
29
2
ROP
48
3
HP
38
4
APH
58
5
YUM
43
3
NAVI
40
7
APA
35
3
KEY
27
3
GIS
37
2
TEL
60
2
O
30
10
Financhill
Back

Riot Platforms 10K Form

Buy
52

RIOT
Riot Platforms

Last Price:
$11.68
Seasonality Move:
16.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RIOT News And Ratings

See the #1 stock for the next 7 days that we like better than RIOT

RIOT Financial Statistics

Sales & Book Value

Annual Sales: $280.7M
Cash Flow: $-179.8M
Price / Cash Flow: 0
Annual Sales: $8.48
Price / Book: 1.46

Profitability

EPS (TTM): 0.20000
Net Income (TTM): $12.4M
Gross Margin: $26.3M
Return on Equity: 0.56%
Return on Assets: 0.53%

Riot Platforms Earnings Forecast

Key Riot Platforms Financial Ratios

  • The Gross Profit Margin over the past 23 years for RIOT is 9.39%.
  • The Selling, General & Administrative Expenses for RIOT have been equal to 35.75% of Gross Profit Margin.
  • The Research & Development expenses have been 7.42% of Revenue.
  • The Interest Expense is -1.92% of Operating Income.
  • The Net Earning history of RIOT is -17.63% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 12 years.

Riot Platforms Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: RIOT
CUSIP: 767292
Website: riotplatforms.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.68
Quick Ratio: 4.57

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 97.25

RIOT Technical Analysis vs Fundamental Analysis

Buy
52
Riot Platforms (RIOT) is a Buy

Is Riot Platforms a Buy or a Sell?

  • Riot Platforms stock is rated a Buy
    The current Riot Platforms [RIOT] share price is $11.67. The Score for RIOT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.